Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20


A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery.

Zhao T, Huang G, Li Y, Yang S, Ramezani S, Lin Z, Wang Y, Ma X, Zeng Z, Luo M, de Boer E, Xie XJ, Thibodeaux J, Brekken RA, Sun X, Sumer BD, Gao J.

Nat Biomed Eng. 2016;1. pii: 0006. doi: 10.1038/s41551-016-0006. Epub 2016 Dec 19.


A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer.

Whitley MJ, Cardona DM, Lazarides AL, Spasojevic I, Ferrer JM, Cahill J, Lee CL, Snuderl M, Blazer DG 3rd, Hwang ES, Greenup RA, Mosca PJ, Mito JK, Cuneo KC, Larrier NA, O'Reilly EK, Riedel RF, Eward WC, Strasfeld DB, Fukumura D, Jain RK, Lee WD, Griffith LG, Bawendi MG, Kirsch DG, Brigman BE.

Sci Transl Med. 2016 Jan 6;8(320):320ra4. doi: 10.1126/scitranslmed.aad0293.


Predictors of Surgery Types after Neoadjuvant Therapy for Advanced Stage Breast Cancer: Analysis from Florida Population-Based Cancer Registry (1996-2009).

Al-Azhri J, Koru-Sengul T, Miao F, Saclarides C, Byrne MM, Avisar E.

Breast Cancer (Auckl). 2015 Dec 13;9:99-108. doi: 10.4137/BCBCR.S31503. eCollection 2015.


Point-of-care and point-of-procedure optical imaging technologies for primary care and global health.

Boppart SA, Richards-Kortum R.

Sci Transl Med. 2014 Sep 10;6(253):253rv2. doi: 10.1126/scitranslmed.3009725. Review.


Intraoperative Ultrasound in the Treatment of Breast Cancer.

Eggemann H, Ignatov T, Beni A, Costa SD, Ortmann O, Ignatov A.

Geburtshilfe Frauenheilkd. 2013 Oct;73(10):1028-1034.


Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-Year results.

Fodor J, Major T, Tóth J, Sulyok Z, Polgár C.

Rep Pract Oncol Radiother. 2011 Jul 27;16(6):227-31. doi: 10.1016/j.rpor.2011.06.005. eCollection 2011.


The value of chest CT for prediction of breast tumor size: comparison with pathology measurement.

Ahn SJ, Kim YS, Kim EY, Park HK, Cho EK, Kim YK, Sung YM, Choi HY.

World J Surg Oncol. 2013 Jun 6;11:130. doi: 10.1186/1477-7819-11-130.


Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer.

Gholami S, Chen CH, Belin LJ, Lou E, Fujisawa S, Antonacci C, Carew A, Chen NG, De Brot M, Zanzonico PB, Szalay AA, Fong Y.

Breast Cancer Res. 2013 Mar 18;15(2):R26. doi: 10.1186/bcr3404.


Usefulness of intraoperative touch smear cytology in breast-conserving surgery.

Sumiyoshi K, Nohara T, Iwamoto M, Tanaka S, Kimura K, Takahashi Y, Kurisu Y, Tsuji M, Tanigawa N.

Exp Ther Med. 2010 Jul;1(4):641-645. Epub 2010 Jul 1.


Breast conservation surgery: state of the art.

White J, Achuthan R, Turton P, Lansdown M.

Int J Breast Cancer. 2011;2011:107981. doi: 10.4061/2011/107981. Epub 2011 Sep 4.


High-frequency ultrasound for intraoperative margin assessments in breast conservation surgery: a feasibility study.

Doyle TE, Factor RE, Ellefson CL, Sorensen KM, Ambrose BJ, Goodrich JB, Hart VP, Jensen SC, Patel H, Neumayer LA.

BMC Cancer. 2011 Oct 12;11:444. doi: 10.1186/1471-2407-11-444.


Technology as a force for improved diagnosis and treatment of breast disease.

Holloway CM, Easson A, Escallon J, Leong WL, Quan ML, Reedjik M, Wright FC, McCready DR.

Can J Surg. 2010 Aug;53(4):268-77. Review.


Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

Jones HA, Antonini N, Hart AA, Peterse JL, Horiot JC, Collin F, Poortmans PM, Oei SB, Collette L, Struikmans H, Van den Bogaert WF, Fourquet A, Jager JJ, Schinagl DA, Wárlám-Rodenhuis CC, Bartelink H.

J Clin Oncol. 2009 Oct 20;27(30):4939-47. doi: 10.1200/JCO.2008.21.5764. Epub 2009 Aug 31.


Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.

Bhattacharyya M, Ryan D, Carpenter R, Vinnicombe S, Gallagher CJ.

Br J Cancer. 2008 Jan 29;98(2):289-93. doi: 10.1038/sj.bjc.6604171. Epub 2008 Jan 22.


Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy.

Moore MM, Borossa G, Imbrie JZ, Fechner RE, Harvey JA, Slingluff CL Jr, Adams RB, Hanks JB.

Ann Surg. 2000 Jun;231(6):877-82.


Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.

Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF.

Br J Cancer. 1999 Dec;81(7):1222-7.


Long-term results of breast conservation therapy for breast cancer.

Neff PT, Bear HD, Pierce CV, Grimes MM, Fleming MD, Neifeld JP, Arthur D, Horsley JS 3rd, Lawrence W Jr, Kornstein MJ.

Ann Surg. 1996 Jun;223(6):709-16; discussion 716-7.


Current management of carcinoma of the breast.

Eberlein TJ.

Ann Surg. 1994 Aug;220(2):121-36. Review.

Supplemental Content

Support Center